Quality of Life Cervical Cancer Patients Stage IB-IIB After Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone
DOI:
https://doi.org/10.61841/57jrnt36Keywords:
Cervical cancer stage IB-IIB, Neoadjuvant Chemotherapy, Quality of LifeAbstract
Cervical cancer is the leading cause of death after breast cancer. The research aimed to determine the effect of giving adjuvant chemotherapy on quality of life in cervical cancer patients stage IB-IIB. Forty-three cervical cancer patients stage IB-IIB who were established based on history taking, physical examination, biopsy, radiology, laboratory, and clinical staging were included in this study. Platinum-based chemotherapy was performed in three to six series, followed by surgery in group one (24 respondents) and surgery alone in group two (19 respondents). The EORTC QLQ 30 and EORTC CX-24 questionnaires were administered after twenty-one days after surgery. An analysis of the results of the post-chemotherapy laboratory results was also carried out, the results of the operating outcomes, and a comparison of estimated treatment costs. Analytical test results showed levels of leukocytes (p = 0.002) and platelets (p = 0.001), which were both lower in the NACT+surgery group. At estimated maintenance costs, p <0.001 was higher in the NACT + surgery group. There are ten respondents with a complete response and nine respondents with a partial response postchemotherapy. Positive LVSI was obtained at 25% vs. 57.89% and lymph node metastasis at 25% vs. 31.58%. From the results of the EORTC QLQ 30 and EORTC CX-24 questionnaires, there were significant values of fatigue symptoms (p = 0.017), appetite loss (p = 0.004), sexual function (p = 0.019), sexual activity (p = 0.033), and enjoyment sexual (p = 0.048) where everything was worse in the NACT + surgery group. Whereas vaginal symptoms were higher in the surgery group alone (p = 0.049). The results of evaluating QoL were lower after NACT administration, and sexuality was the most affected in the NACT group. But NACT administration improves operability and histopathological results
Downloads
References
1. Araujo J.K.L. et al. (2017). Chemotherapy-Induced Fatigue Correlates With Higher Fatigue Scores Before
Treatment. American Journal of Hospice and Palliative Medicine®. 34(5): 404-411.
2. Bjelic R.V. et al. (2012). Quality of life characteristics inpatients with cervical cancer. European journal
of cancer. 1;48(16): 3009-18.
3. Boussios, S., Pentheroudakis, G., Katsanos, K., and Pavlidis, N. (2012). Systemic treatment-induced
gastrointestinal toxicity: incidence, clinical presentation, and management. Annals of gastroenterology,
25(2), p.106.
4. Cho Y.H. et al. (2009). Comparative study of neoadjuvant chemotherapy before radical hysterectomy and
radical surgery alone in stage IB2-IIA bulky cervical cancer. Journal of gynecologic oncology. 20(1): 22-
27.
5. Dahiya N et al. (2016). Quality of life of patients with advanced cervical cancer before and after chemoradiotherapy. Asian Pacific Journal of Cancer Prevention. 17(7): 3095-3099.
6. Kemenkes RI. (2016). Permenkes 64. Tarif dasar pelayanan kesehatan dalam penyelenggaraan BPJS.
7. Lavdaniti M. & Tsitsis N. (2015). Definitions and conceptual models of quality of life in cancer patients. Health Science Journal. 9(2): 1.
8. Marks M et al. (2011). Combined oral contraceptive use increases HPV persistence but not new HPV
detection in a cohort of women from Thailand. Journal of Infectious Diseases. 204(10): 1505-1513.
9. Oun R et al. (2018). The side effects of platinum-based chemotherapy drugs: a review for chemists.
Dalton transactions. 47(19): 6645-6653.
10. Prasongvej P et al. (2017). Quality of Life in Cervical Cancer Survivors and Healthy Women: Thai Urban
Population Study. Asian Pacific journal of cancer prevention: APJCP. 18(2): 385.
11. Reynoso N.N. et al. (2017). Cervical cancer epidemiology. In : de la Garza-Salazar JG, Moralez-Varquez
F, Meneses-Garcia A, editors. Cervical Cancer. Switzerland: Springer. p. 19-21.
12. Rocconi, R.P., Estes, J.M., Leath III, C.A., Kilgore, L.C., Huh, W.K., and Straughn Jr., J.M., 2005.
Management strategies for stage II cervical cancer: a cost-effectiveness analysis. Gynecologic
oncology, 97(2), pp. 387-394.
13. Sekse R.J.T. et al. (2010). Life beyond cancer: women’s experiences 5 years after treatment for
gynaecological cancer. Scandinavian Journal of Caring Sciences. 24(4): 799-807.
14. Simonelli L.E. et al. (2017). Fear of cancer recurrence: a theoretical review and its relevance for clinical
presentation and management. Psycho‐oncology.26(10): 1444-1454.
15. Wahidin M. (2015). Deteksi dini kanker leher Rahim dan kanker payudara diIndonesia tahun 2007-2014. Buletin jendela data dan informasi kesehatan. 1:9-13.
16. Xiao M et al. (2016). Quality of life and sexuality in disease-free survivors of cervical cancer after radical hysterectomy alone: a comparison between total laparoscopy and laparotomy. Medicine. 95(36).
17. Yin M et al. (2011). The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Int J Gynecol Cancer. 21(1): 92-9.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
